Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Dec:67:152215.
doi: 10.1016/j.anndiagpath.2023.152215. Epub 2023 Oct 5.

Spitz tumor with RAF1 fusion: A report of 3 cases

Affiliations
Free article
Case Reports

Spitz tumor with RAF1 fusion: A report of 3 cases

Michele Donati et al. Ann Diagn Pathol. 2023 Dec.
Free article

Abstract

Spitz tumors are melanocytic neoplasms morphologically characterized by spindled and/or epithelioid cells and specific stromal and epidermal changes associated with mutually exclusive fusion kinases involving ALK, ROS1, NTRK1, NTRK2, NTRK3, MET and RET, BRAF and MAP3K8 genes or, less commonly, HRAS mutation. RAF1 fusions have been recently detected in cutaneous melanocytic neoplasms, including conventional melanoma, congenital nevus and BAP-1 inactivated tumors. We report herewith three Spitz neoplasms with a RAF1 fusion, including a previously reported CTDSPL::RAF1 fusion and two novel PPAP2B::RAF1 and ATP2B4::RAF1 fusions. Two cases were classified as Spitz nevus, while the remaining neoplasm was classified as Spitz melanoma at the time of the diagnosis, given 9p21 homozygous deletion and positive sentinel lymph node biopsy. We suggest that RAF1 fused melanocytic neoplasms can represent a novel subgroup of Spitz tumors, with a RAF1 fusion representing an oncogenic driver.

Keywords: RAF1 fusion; Spitz tumor; Unusual melanocytic neoplasms; spitzoid morphology.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Dr. Gerami has served as a consultant for DermTech Inc. and Castle Biosciences and has received royalties for textbooks from Elsevier. All other authors report no conflicts of interest.

Similar articles

Cited by

Publication types

MeSH terms

Substances